INBX
Inhibrx Biosciences, Inc. · Healthcare
Viking Global Investors LP bought $3.4M of Inhibrx Biosciences, Inc.
10% owner
Bought$3,409,866
$18.92Price
180,219Shares
+4%Stake
What INBX did for a copier
- $1,000 copied at Mon, Aug 31 open, $18.40
- $1,027
- S&P 500, same days
- +0.3%
Measured over 30 trading days, to the Oct 13 close.
Viking Global Investors LP's record
6 other buys with 3 months of prices since 2018: on average −6.1% against the S&P 500, and 3 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Aug 26. Filed Fri, Aug 28, 4:29 PM ET, after the close. Returns use the Aug 31 open and the Oct 13 close. Not investment advice.